US Stock Futures Mostly Lower Ahead Of Wholesale Data
US stock futures traded mostly lower in early pre-market trade, ahead of wholesale data. The producer price index for July will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dropped 18 points to 15,393.00, while the Standard & Poor's 500 index futures fell 2.70 points to 1,688.10. Futures for the Nasdaq 100 index rose 0.75 points to 3,137.75.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index dropping 0.17%, London's FTSE 100 index surging 0.08% and STOXX Europe 600 Index rising 0.12%. German DAX 30 index gained 0.15% and French CAC 40 Index rose 0.28%. Euro-zone gross domestic product increased 0.3% in the second quarter versus the earlier quarter. German gross domestic product grew 0.7% in the second quarter, versus economists' expectations for a 0.6% rise. France GDP rose 0.5% in the second quarter versus the first quarter, beating estimates of a 0.2% increase. French consumer prices declined 0.3% in July versus June.
Asian markets ended mixed today. Australian consumer sentiment increased 3.5% to 105.7 points in August from July, the Westpac Banking Corp/Melbourne Institute reported. China's Shanghai Composite declined 0.29%, while Japan's Nikkei Stock Average jumped 1.32%. Australia's ASX/S&P500 dropped 0.01% and India's Sensex surged 0.72%.
Analysts at JP Morgan upgraded Western Union Company (NYSE: WU) from “underweight” to “neutral.” The target price for Western Union has been raised from $17 to $18.
Western Union's shares closed at $18.65 yesterday.
- JinkoSolar Holding Co (NYSE: JKS) posted a profit in the second quarter. JinkoSolar posted a quarterly net income of $8 million, or $0.36 per American Depositary Share (ADS), versus a year-ago net loss of $48.9 million, or $2.20 per ADS. To read the full news, click here.
- Diamondback Energy (NASDAQ: FANG) announced today the launch of an underwritten public offering of 4,000,000 shares of its common stock, subject to market and other conditions. To read the full news, click here.
- MannKind (NASDAQ: MNKD) today announced positive preliminary results from Study 175, a Phase 3 clinical study of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder, an investigational, ultra rapid-acting mealtime insulin therapy administered using MannKind's next-generation (Gen2) inhaler, in patients with type 2 diabetes. To read the full news, click here.
- Deere & Co (NYSE: DE) reported a rise in its third-quarter profit. Deere's quarterly profit surged to $997 million, or $2.56 per share, from $788 million, or $1.98 per share, in the year-ago period. To read the full news, click here.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.